Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 When should antiretroviral therapy be started for HIV infection? Interpreting the evidence from observational studies.

Literature DB >> 12960818

When should antiretroviral therapy be started for HIV infection? Interpreting the evidence from observational studies.

Andrew N Phillips, Alessandro Cozzi Lepri, Fiona Lampe, Margaret Johnson, Caroline A Sabin.

Abstract

Entities: Disease

Mesh：

Substances：
Anti-HIV Agents

Year: 2003 PMID： 12960818 DOI： 10.1097/00002030-200309050-00004

Source DB: PubMed Journal: AIDS ISSN： 0269-9370 Impact factor: 4.177

Keyword Cloud
Cited

× No keyword cloud information.

18 in total

Review 1. The impact of disease stage on direct medical costs of HIV management: a review of the international literature.

Authors: Adrian Levy; Karissa Johnston; Lieven Annemans; Andrea Tramarin; Julio Montaner
Journal: Pharmacoeconomics Date: 2010 Impact factor: 4.981

2. Highly active antiretroviral therapy.

Authors: Filip Moerman; Alfons Van Gompel; Jan Nimmegeers; Johan Moerman
Journal: BMJ Date: 2005-06-11

Review 3. When to start antiretroviral therapy.

Authors: Cunlin Wang; Saba W Masho; Daniel E Nixon
Journal: Curr HIV/AIDS Rep Date: 2006-07 Impact factor: 5.071

Review 4. When should antiretroviral therapy for HIV be started?

Authors: Andrew N Phillips; Brian G Gazzard; Nathan Clumeck; Marcelo H Losso; Jens D Lundgren
Journal: BMJ Date: 2007-01-13

5. Change over time of mortality predictors after HAART initiation in a Senegalese cohort.

Authors: Pierre De Beaudrap; Jean-François Etard; René Ecochard; Assane Diouf; Allé Baba Dieng; Vannina Cilote; Ibrahima Ndiaye; Ndèye Fatou Ngom Guèye; Pape Mandoumbé Guèye; Papa Salif Sow; Souleymane Mboup; Ibra Ndoye; Eric Delaporte
Journal: Eur J Epidemiol Date: 2008-01-16 Impact factor: 8.082

6. Using mechanistic models to simulate comparative effectiveness trials of therapy and to estimate long-term outcomes in HIV care.

Authors: Mark S Roberts; Kimberly A Nucifora; R Scott Braithwaite
Journal: Med Care Date: 2010-06 Impact factor: 2.983

When should antiretroviral therapy be started for HIV infection? Interpreting the evidence from observational studies.

Review 1. The impact of disease stage on direct medical costs of HIV management: a review of the international literature.

2. Highly active antiretroviral therapy.

Review 3. When to start antiretroviral therapy.

Review 4. When should antiretroviral therapy for HIV be started?

5. Change over time of mortality predictors after HAART initiation in a Senegalese cohort.

6. Using mechanistic models to simulate comparative effectiveness trials of therapy and to estimate long-term outcomes in HIV care.

7. Factors Associated With Retention Among Non-Perinatally HIV-Infected Youth in the HIV Research Network.

8. The therapeutic implications of timely linkage and early retention in HIV care.

Review 9. When to start antiretroviral therapy.

10. Clinical course and quality of care in ART-naïve patients newly presenting in a HIV outpatient clinic.